Viewing Study NCT02162732


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-02-20 @ 12:35 PM
Study NCT ID: NCT02162732
Status: COMPLETED
Last Update Posted: 2025-11-03
First Post: 2014-06-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Molecular-Guided Therapy for Childhood Cancer
Sponsor: Giselle Sholler
Organization:

Study Overview

Official Title: Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: COMPLETED
Status Verified Date: 2025-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to test the feasibility (ability to be done) of experimental technologies to determine a tumor's molecular makeup. This technology includes a genomic report based on DNA exomes and RNA sequencing that will be used to discover new ways to understand cancers and potentially predict the best treatments for patients with cancer in the future.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: